Lewis v. Hickel Investment Company, 082218 AKWC, 18-0084

Case DateAugust 22, 2018
CourtAlaska
RANDALL LEWIS, Employee, Claimant,
v.
HICKEL INVESTMENT COMPANY, Employer,
and
ALASKA NATIONAL INSURANCE, Insurer, Defendants.
AWCB No. 201514492
AWCB Decision No. 18-0084
Alaska Workers’ Compensation Board
August 22, 2018
          FINAL DECISION AND ORDER           HENRY TASHJIAN, DESIGNATED CHAIR.          Randall Lewis’s May 11, 2016 claim for benefits was heard on July 24, 2018 in Anchorage, Alaska, a date selected on May 22, 2018. Randall Lewis (Employee) appeared and represented himself. Attorney Michelle Meshke appeared and represented Hickel Investment Company and Alaska National Insurance (Employer). No witnesses testified. The record closed at the hearing’s conclusion on July 24, 2018.          ISSUES          Employee raised preliminary issues, contending that late filing of his evidence packet and witness list should be excused. In the alternative, Employee requested continuance of the hearing so that he would be able to continue treatment and further prepare for hearing.          Employer stipulated to admission of Employee’s medical records, but opposed admission of the remainder of the late-filed evidence and Employee’s witness list, arguing acceptance of these filings would be prejudicial to Employer, and their exclusion would not cause manifest injustice. Employer opposed continuance, stating that no good cause existed for the request.          At hearing, an oral order was issued excluding the late-filed witness list and evidence and denying continuance.          1. Was the oral order excluding late-filed documents correct?          2. Was the oral order denying continuance correct?          Employee contends he is entitled to workers’ compensation benefits including temporary total disability (TTD), permanent total disability (PTD), medical costs, transportation costs, penalty, interest, unfair or frivolous controversion, and attorney fees and costs. Employee further contends a reemployment benefits eligibility determination should be reviewed and overturned, and requests a monetary award of $20,000,000.00.          Employer contends it has paid the benefits due to Employee under the Act, and that Employee has not met the evidentiary burden of showing he is entitled to his requested awards. Employer contends no basis in law or fact exists for Employee’s requested monetary award.          3. Is Employee entitled to compensation for TTD?          4. Is Employee entitled to compensation for PTD?          5. Is Employee entitled to compensation for medical costs?          6. Is Employee entitled to compensation for transportation costs?          7. Is Employee entitled to penalty and interest?          8. Is Employee entitled to a finding of unfair or frivolous controversion?          9. Is Employee entitled to review or modification of the eligibility determination?          10. Is Employee entitled to a monetary award?          11. Is Employee entitled to attorney fees and costs?          FINDINGS OF FACT          The following facts are established by a preponderance of the evidence:          1) On July 29, 2005, Employee was examined by Catherine Giessel, FNP-CS. FNP Giessel reported Employee complained of neck pain, which he had not previously described. (Giessel Report, July 29, 2005).          2) On February 22, 2008, Employee was examined by Jane Sonnenburg, PA-C, at Orthopedic Physicians Anchorage. Employee reported symptoms including left shoulder pain, and PA Sonnenburg, after reviewing x-ray imaging, diagnosed osteoarthritis of the left shoulder AC joint and glenohumeral joint. (Sonnenburg Report, February 22, 2008).          3) On April 20, 2015, Employee was examined by his treating physician, T. Noah Laufer, M.D. He reported pain in his right hip, left shoulder, and back. (Laufer Report, April 20, 2015).          4) On August 30, 2015, Employee reported he had sustained a repetitive motion injury to his cervical spine while working for Employer. (MTC First Report of Injury, September 14, 2015).          5) On September 3, 2015, Employee reported to Dr. Laufer that he had felt a twinge in his neck the previous Sunday around noon, and symptoms increased the rest of the day. He reported decreased range of motion, pain, muscle spasms (right greater than left over the trapezius muscles), and numbness and weakness of the right arm. He did not identify a specific trauma, but indicated he had been busy and performing frequent manual labor at work over a short period of time. Dr. Laufer released Employee from work until September 8, 2015. (Laufer Report, September 3, 2015; Laufer Work Note, September 3, 2015).          6) Employer has paid TTD benefits from September 1, 2015 through March 9, 2016. (Compensation Report, March 18, 2016; See also Work Notes, Laufer, September 11, 2015, September 21, 2015, September 30, 2015, January 29, 2016, February 29, 2016, Work Notes, Gevaert, October 12, 2015, October 27, 2015, November 6, 2015, Work Note, Kropp, December 18, 2015, December 30, 2015, January 7, 2016).          7) On September 3, 2015, on referral from Dr. Laufer, Employee obtained a magnetic resonance imaging (MRI) study. John McCormick, M.D. found straightening of the cervical lordosis and marked disc space narrowing at C5-6 and C6-7 with large anterior osteophytes. He found no fractures or malignant changes, and stated the foramen were preserved and soft tissues were normal. (McCormick Report, September 3, 2015).          8) On September 4, 2015, Dr. Laufer reviewed Employee’s imaging, stating it showed “multilevel severe degenerative disease with neural impingement, but no acute process such as a ruptured disc or fracture.” He opined Employee’s symptoms were consistent with a formation flare, and Employee might benefits from a steroid injection or surgery. (Laufer Report, September 4, 2015).          9) On September 11, 2015, Dr. Laufer referred Employee to the Alaska Spine Institute for specialized examination and treatment. (Laufer Report, September 11, 2015).          10) On October 12, 2015, Employee was evaluated by Michel L. Gevaert at the Alaska Spine Institute. Dr. Gevaert reviewed the September 4, 2015 MRI, noting it showed “diffuse degenerative disc disease from C4 through C7, most severe at C5 and C6. There is foraminal stenosis of the right C5-6.” He noted past medical history including chronic low back pain, chronic neck pain in 2005, arthritis, asthma, and hypertension. His diagnoses included severe neck pain and pain referral in both upper extremities, sensory loss in the left upper extremity, positive Waddell signs, and a history of alcohol abuse. He prescribed MS Contin, Percocet, Norco, and Valium, and noted that currently-prescribed medications were Lisinopril, atorvastatin, morphine sulfate, diazepam, Valium, Norco, and Percocet. Employee reported better control with Valium than opioids, and was reluctant to escalate opioids. (Gevaert Report, October 12, 2015).          11) On October 16, 2015, Dr. Gevaert performed a nerve conduction study, which indicated bilateral carpal tunnel syndrome affecting motor and sensory nerve fibers, normal ulnar nerve conduction study, and no electromyographic evidence of cervical radiculopathy. He opined Employee could benefit from physical therapy, and switched his prescription from Percocet to Roxicodone. Dr. Gevaert listed Employee’s current prescribed medications as Roxicodone, amlodipine, hydrochlorothiazide, MS Contin, and Vicodin. (Gevaert Report, October 16, 2015).          12) On November 12, 2015, Dr. Gevaert administered Employee an epidural steroid injection. (Gevaert Surgical Report, November 12, 2015).          13) On December 2, 2015, Employee was evaluated by Dr. Gevaert. Dr. Gevaert stated he had a long discussion with Employee, and expressed concern with his delayed recovery 4-month span of off-work status, “despite extensive physical therapy, appropriate pain management and one epidural steroid injection.” Employee showed an altered pain perception, and agreed to return to work full-duty for four hours per day, while continuing with physical therapy and pain management. Dr. Gevaert planned a follow-up appointment with Employee “to evaluate if this strategy is effective,” and issued a prescription for a home traction device and Biofreeze. Employee was given a random drug screen, which found Nordiazepam, Oxazepam, Temazepam, Hydromorphone, and morphine, all of which were labeled inconsistent with Employee’s prescribed medications. The most recent...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT